Ticagrelor to prevent restenosis: new drug for an old hypothesis?

Arterioscler Thromb Vasc Biol. 2010 Dec;30(12):2320-2. doi: 10.1161/ATVBAHA.110.216267.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Adenosine / analogs & derivatives*
  • Adenosine / pharmacology
  • Animals
  • Blood Coagulation / drug effects
  • Blood Platelets / drug effects
  • Blood Platelets / metabolism
  • Carotid Artery Injuries / metabolism
  • Carotid Artery Injuries / pathology
  • Carotid Artery Injuries / prevention & control*
  • Carotid Artery, Common / drug effects
  • Carotid Artery, Common / pathology
  • Carotid Stenosis / metabolism
  • Carotid Stenosis / pathology
  • Carotid Stenosis / prevention & control*
  • Cell Proliferation / drug effects
  • Coronary Restenosis / metabolism
  • Coronary Restenosis / pathology
  • Coronary Restenosis / prevention & control*
  • Fibrinolytic Agents / pharmacology*
  • Humans
  • Mice
  • P-Selectin / blood
  • Platelet Aggregation / drug effects
  • Platelet Aggregation Inhibitors / pharmacology*
  • Purinergic P2Y Receptor Antagonists / pharmacology*
  • Receptors, Purinergic P2Y12 / drug effects
  • Receptors, Purinergic P2Y12 / metabolism
  • Thrombosis / blood
  • Thrombosis / prevention & control
  • Ticagrelor
  • Tunica Intima / drug effects
  • Tunica Intima / pathology

Substances

  • Fibrinolytic Agents
  • P-Selectin
  • P2ry12 protein, mouse
  • Platelet Aggregation Inhibitors
  • Purinergic P2Y Receptor Antagonists
  • Receptors, Purinergic P2Y12
  • Ticagrelor
  • Adenosine